abrdn plc boosted its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) by 3.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 442,466 shares of the biotechnology company’s stock after buying an additional 14,401 shares during the quarter. abrdn plc owned 0.62% of Axon Enterprise worth $73,418,000 at the end of the most recent quarter.
Several other large investors have also bought and sold shares of the company. U.S. Capital Wealth Advisors LLC purchased a new stake in Axon Enterprise in the 4th quarter worth about $29,000. Roble Belko & Company Inc purchased a new stake in shares of Axon Enterprise during the 4th quarter worth about $33,000. North Star Investment Management Corp. purchased a new stake in shares of Axon Enterprise during the 4th quarter worth about $41,000. EverSource Wealth Advisors LLC purchased a new stake in shares of Axon Enterprise during the 4th quarter worth about $42,000. Finally, Accurate Wealth Management LLC purchased a new stake in shares of Axon Enterprise during the 4th quarter worth about $49,000. Institutional investors own 75.62% of the company’s stock.
Axon Enterprise Stock Performance
AXON stock opened at $201.17 on Wednesday. The firm has a market cap of $14.86 billion, a PE ratio of 106.46 and a beta of 0.95. The company has a quick ratio of 2.97, a current ratio of 3.33 and a debt-to-equity ratio of 0.48. The business has a 50 day moving average of $217.43 and a 200-day moving average of $195.52. Axon Enterprise, Inc. has a 12-month low of $83.01 and a 12-month high of $229.95.
Axon Enterprise (NASDAQ:AXON – Get Rating) last posted its quarterly earnings data on Tuesday, February 28th. The biotechnology company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.08 by $0.28. Axon Enterprise had a return on equity of 10.65% and a net margin of 10.76%. The business had revenue of $336.14 million for the quarter, compared to the consensus estimate of $303.91 million. As a group, sell-side analysts expect that Axon Enterprise, Inc. will post 0.97 earnings per share for the current year.
Insider Activity at Axon Enterprise
In related news, Director Mark W. Kroll sold 3,549 shares of the company’s stock in a transaction that occurred on Tuesday, March 7th. The stock was sold at an average price of $220.73, for a total value of $783,370.77. Following the transaction, the director now owns 10,142 shares in the company, valued at $2,238,643.66. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 591 shares of the stock in a transaction on Friday, March 3rd. The stock was sold at an average price of $212.52, for a total transaction of $125,599.32. Following the sale, the director now owns 8,179 shares in the company, valued at $1,738,201.08. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Mark W. Kroll sold 3,549 shares of the stock in a transaction on Tuesday, March 7th. The stock was sold at an average price of $220.73, for a total value of $783,370.77. Following the sale, the director now owns 10,142 shares in the company, valued at approximately $2,238,643.66. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 99,290 shares of company stock worth $21,547,805. Insiders own 6.10% of the company’s stock.
Analyst Ratings Changes
A number of brokerages recently weighed in on AXON. The Goldman Sachs Group assumed coverage on Axon Enterprise in a research note on Tuesday, March 7th. They issued a “buy” rating and a $263.00 price objective on the stock. TheStreet upgraded Axon Enterprise from a “c” rating to a “b-” rating in a research report on Tuesday, May 9th. StockNews.com began coverage on Axon Enterprise in a research report on Thursday, March 16th. They issued a “hold” rating for the company. JMP Securities reaffirmed a “market outperform” rating and set a $235.00 price objective on shares of Axon Enterprise in a research note on Friday, April 14th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $240.00 target price on shares of Axon Enterprise in a research note on Thursday, April 13th. Two analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $232.64.
Axon Enterprise Profile
Axon Enterprise, Inc engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Axon Enterprise wasn’t on the list.
While Axon Enterprise currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Elon Musk’s Next Move
Wondering when you’ll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
